Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Diabetic footwear is specially designed footwear that offer security for diabetic feet and lessen the danger of skin breakdown caused by poor flow, neuropathy, and foot disfigurements. The diabetic footwear accompanies assortment of highlights, for example, stretchable uppers, non-restricting uppers, orthotic bolster, additional profundity plan for weight free fit, profound toe-box, utilitarian bottoms, and others. Diabetic footwear is biomechanically built and are frequently utilized by competitors and customary individuals experiencing foot deformations caused by diabetes. According to the W.H.O, in 2014, 8.5% of adults aged 18 years and older had diabetes. Likewise, in 2016, diabetes was the direct cause of 1.6 million deaths and in 2012, high blood glucose was the cause of another 2.2 million deaths globally. Hence, owing to the high prevalence rate of diabetes around the world is expected to fuel the artificial pancreas devices market in near future.
Rising prevalence of the diabetes basically drives the diabetic footwear market growth. As indicated by International Diabetes Federation (IDF), around 642 million people anticipated to have diabetes by 2040. This is anticipated to provide a major impetus to the diabetic shoes market. A In addition, quick progression saw in Internet infiltration, rising life expectancy, and development in prevalence of online shopping market throughout the most recent decade expand the development of the market. The advancement in knowledge with respect to diabetes and advantages of diabetic footwear further drive the development of the diabetic footwear market. Diabetic footwear is relied upon to gain popularity on online portals sooner rather than later with couple of restrictions, for example, lesser knowledge of the advantages of the diabetic shoes and negligence with respect to diabetic patient
The various types shoe, sandal, and slipper are available in the market for diabetes patients. The shoe type is most popular choice observed among diabetic populace. Shoes for patients living with diabetes are made of special protective inserts and soft shoe materials to accommodate for conditions, such as neuropathy, poor circulation and foot deformities. The shoes decrease the chance of foot sores (ulcers), which can be caused by friction and pressure. The rising awareness about the different styles of diabetic footwear boosts the growth of the footwear type segment during the forecast period. Shoe is also preferable to office going population since a formal attire includes shoe. The features such as added protection, option to wear shoes on virtually any occasion or place increases the demand for these shoes, which boosts the growth of this segment in the market.
The various distribution channels of diabetic footwear are online platform, specialty store, and footwear store among others. The specialty store distribution channel specialty store is a preferred choice by the consumers and healthcare professionals as these shoes require proper fitting and expert guidance before their use, which is difficult with online platforms. The factor of immediate gratification coupled with the option of trail before purchase gives the specialty store distribution channel segment a major draw.
Diabetic footwear is used among both men’s and women. The market of diabetic footwear in women end user observed to be higher as compared to the men. This is mainly due to higher number of women diabetic patients. Rise in awareness among women about the effects of diabetes on the body, improvement in online retail penetration, and foot care among diabetic patients drive the growth of the market.
On the basis of regional presence, global diabetic footwear market is segmented into North America, Europe, Asia Pacific, and Rest of the World (ROW).
North America is expected dominate the market as well as grow at a steady pace in the diabetic footwear market followed by Europe. The rise in geriatric population along with launch of improved diabetic footwear is expected to boost the growth of the diabetic footwear market in North America. U.S held the major revenue share of the market. Increasing awareness among diabetic patients in the US is further supporting the market growth in North America supported by substantial investment in health and wellness.
Further, the Asia-Pacific segment is the fastest growing market mainly because of the surge in population, increase in aging population, rise in disposable income, and growth in awareness about diabetes and its impact on foot health. Further, many key players are investing in Asia-Pacific region as the dominance of type 2 diabetes shows a wide range across adult populations from approximately 2% in the Peoples Republic of China.
The leading players in the diabetic footwear market have focused on providing customized solutions to consumers as their key strategies to gain a significant share in the market. Strategies such as product launch and acquisition have also helped the key players to gain a significant share in the global diabetic footwear market. The key players profiled in the report include Podartis Srl (Italy), DJO Global Inc. (U.S.), Aetrex Worldwide, Inc. (U.S.), Dr. Zen Products, Inc. (U.S.), Orthofeet Inc. (U.S.), Propet USA, Inc. (U.S.), I-Runner (U.S.), Pilgrim shoes (U.S.), Finn Comfort (U.S.), and Drew Shoes (U.S.).
